ArticleFrontiers in cellular and infection microbiology2025
Epidemiological trends of influenza A and B in one hospital in Chengdu and national surveillance data (2019-2024).
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Epidemiology of SARS-CoV-2, Influenza, RSV, and Human Metapneumovirus Across the COVID-19 Era: An Eight-Year Tertiary-Center Study in Saudi Arabia.Pathogens (Basel, Switzerland) · 2026Observational
- Asymmetric post-pandemic recovery of influenza A and B since 2020 in Hong Kong: an interrupted time-series (ITS) analysis of weekly surveillance data with subtype and lineage characterization.BMC infectious diseases · 2026Article
- Article
- Comparison of respiratory pathogen infections in hospitalized patients before and during the COVID-19 pandemic in Shanghai, China.Microbiology spectrum · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Influenza A (Flu A) and Influenza B (Flu B) are major contributors to seasonal epidemics, causing significant morbidity and mortality worldwide. Understanding their epidemiological trends is essential for optimizing prevention and control strategies. Objective: This study aims to analyze the epidemiological trends of Flu A and Flu B, compare hospital-based and national surveillance data, and evaluate the impact of COVID-19 on influenza transmission to provide scientific evidence for influenza control measures. Methods: We analyzed influenza positivity rates from Sichuan Jinxin Xinan Women and Children Hospital data (HD) and Chinese National Influenza Center (CNIC) between 2019 and 2024. Temporal trends, subtype distributions, and the effects of non-pharmaceutical interventions (NPIs) were assessed. Results: Influenza activity exhibited significant temporal variations. In HD, the highest cumulative positivity rate of Flu A + Flu B was observed in 2023 (31.9%), whereas the lowest rate occurred during the COVID-19 pandemic (2020-2022), with a nadir in 2021 (2.0%). Flu A remained the predominant subtype in HD except in 2021, whereas CNIC data showed a relatively higher proportion of Flu B. Weekly positivity rates displayed distinct seasonal trends in CNIC data but not in HD. A comparative analysis of pre-pandemic (2019), pandemic (2020-2022), and post-pandemic (2023-2024) phases indicated that NPIs had a stronger suppressive effect on Flu A than on Flu B. Conclusion: Hospital-based and national influenza surveillance data showed heterogeneity in subtype proportions, seasonal trends, and pandemic-related impacts. These findings underscore the importance of integrating multiple surveillance sources for a comprehensive understanding of influenza dynamics. Enhancing vaccine coverage, implementing targeted public health interventions, and optimizing resource allocation are crucial for mitigating the influenza burden in the post-pandemic era.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.